BestPhorm21 - Boosting Europe's Sovereignty in Technology by driving Photonics from Research to Market - Photonics21 (DCM.AD006.317)
Area tematica
Scienze chimiche e tecnologie dei materiali
Area progettuale
Chimica e tecnologia dei materiali (DCM.AD006)Struttura responsabile del progetto di ricerca
Istituto per lo studio dei materiali nanostrutturati (ISMN)
Altre strutture che collaborano al progetto di ricerca
Responsabile di progetto
GABRIELLA LEO
Telefono: 06-90672807
E-mail: gabriella.leo@cnr.it
Abstract
BestPhorm21 will provide the decisive support to Horizon Europe's "Photonics Partnership", which is currently established between the EU Commission and Photonics21, to stimulate the growth of the European photonics industry. The project is led by the Photoncs21 Secretariat, VDITZ, in partnership with 14 National Technology Platforms, representing Europe's photonics industry, Research and Technology Organisations (RTOs) and clusters. BestPhorm21 will develop a community driven European photonics industrial strategy and roadmap, engaging over 3,000 experts from industry and academia, that will guide Horizon Europe and industrial investments in R&D and advanced manufacturing. BestPhorm21 thus makes a significant contribution to increasing European technological sovereignty in a key digital technology such as photonics. It will furthermore establish new strategic value chains between photonics and end user industries, through the delivery of 7 additional "photonics enabled" end user industry roadmaps. This will be done in close cooperation with the respective industry stakeholders organsiations, more than 700 experts from both the photonics and end-user industries will be involved.
Obiettivi
The industrial strategy will result in new product launches and services that drive sales growth and support the digitalization of these sectors. BestPhorm21 will trigger cross-member state and regional investments, which mobilise and leverage Europe's full innovation ecosystem to keep Europe at the global forefront in photonics R&D and technology development, delivering cross-member state calls valued at > EUR 10 m and 5 interregional investment projects. Finally, BestPhorm21 increases access to risk finance for over 300 photonics start-ups and SMEs in their critical growth phases, through "blended finance" (European Investment Council's Accelerator), "Venture Capital" (dedicated VC events) and "Venture debt" (European Investment Bank).
Data inizio attività
01/01/2021
Parole chiave
Photonics, photonics partnership, photonics strategic R&I agenda
Ultimo aggiornamento: 21/04/2025